These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9092641)

  • 1. Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA.
    Parks D; Bolinger R; Mann K
    Nucleic Acids Res; 1997 Mar; 25(6):1289-95. PubMed ID: 9092641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding.
    Delphin C; Cahen P; Lawrence JJ; Baudier J
    Eur J Biochem; 1994 Jul; 223(2):683-92. PubMed ID: 8055938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.
    Lin SR; Yang YC; Jung JH; Tsai JH
    DNA Cell Biol; 1996 Oct; 15(10):793-803. PubMed ID: 8892752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N terminus of p53 regulates its dissociation from DNA.
    Cain C; Miller S; Ahn J; Prives C
    J Biol Chem; 2000 Dec; 275(51):39944-53. PubMed ID: 10993878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of p53 transcriptional activity by 1,10-phenanthroline, a metal chelator and redox sensitive compound.
    Sun Y; Bian J; Wang Y; Jacobs C
    Oncogene; 1997 Jan; 14(4):385-93. PubMed ID: 9053835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53.
    Yap N; Yu CL; Cheng SY
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4273-7. PubMed ID: 8633054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
    Hainaut P; Milner J
    Cancer Res; 1993 Oct; 53(19):4469-73. PubMed ID: 8402615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein.
    Foord O; Navot N; Rotter V
    Mol Cell Biol; 1993 Mar; 13(3):1378-84. PubMed ID: 8441383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism.
    Hainaut P; Rolley N; Davies M; Milner J
    Oncogene; 1995 Jan; 10(1):27-32. PubMed ID: 7824276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53 transactivation through high-affinity binding sites.
    Chumakov AM; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
    Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
    Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of p53 with its consensus DNA-binding site.
    Wang Y; Schwedes JF; Parks D; Mann K; Tegtmeyer P
    Mol Cell Biol; 1995 Apr; 15(4):2157-65. PubMed ID: 7891710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
    Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
    Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature sensitivity for conformation is an intrinsic property of wild-type p53.
    Hainaut P; Butcher S; Milner J
    Br J Cancer; 1995 Feb; 71(2):227-31. PubMed ID: 7841034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.
    Jayaraman J; Prives C
    Cell; 1995 Jun; 81(7):1021-9. PubMed ID: 7600571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different recognition of DNA modified by aatitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53.
    Kasparkova J; Pospisilova S; Brabec V
    J Biol Chem; 2001 May; 276(19):16064-9. PubMed ID: 11279186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization.
    Sun XZ; Vinci C; Makmura L; Han S; Tran D; Nguyen J; Hamann M; Grazziani S; Sheppard S; Gutova M; Zhou F; Thomas J; Momand J
    Antioxid Redox Signal; 2003 Oct; 5(5):655-65. PubMed ID: 14580323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
    Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
    Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.